An Australian stem cell and regenerative medicine company

February 06, 2025

February 2025 Investor Webinar

Today, Cynata's CEO and MD, Dr Kilian Kelly and CBO Dr Mathias Kroll, provided an update to investors, following the release of the ASX Quarterly Activity Report for the December 2024 quarter.